ALPHADERM
Timeline
15 events since 2019Capital
Filings
Financial
Establishments
Address
Other
2020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBmicro format · 43 days before the deadline
2025
Annual accounts 2024 filed PDFmicro format · 29 days before the deadline
2024
Registered office moved from Oudenaarde to NukerkeNew registered office: Rijksweg 71 te 9681 Nukerke · Previous registered office: Jezuietenplein 14 te 9700 Oudenaarde · Board meeting of 17-03-20242 points ▸
- Board meeting, 17-03-2024
- Registered-office move, Rijksweg 71 te 9681 Nukerke
Demerger proposal: ALPHADERM splits off to ALPHA STAY BVFounding capital of €128,7, 25,742 shares8 points ▸
- Founding capital, €128,7, 25,742 shares
- Board composition, Viviane Staelens (director)
- Board composition, Sarah De Pauw (director)
- Board composition, Eva De Pauw (director), mentioned twice in the deed
- Board composition, De Pauw Jozef (managing director)
- Board composition, Staelens Viviaene (managing director)
- Capital, €500, 25,742 shares
- Board composition, Viviane Staelens (managing director)
- The deed holds 24 more points.
Annual accounts 2023 filed PDFmicro format · 48 days before the deadline
2023
Registered in the Peppol Directory Reachable for e-invoices through 0208:0732510346
Annual accounts 2022 filed PDFmicro format · 39 days before the deadline
2022
Highest result from 2019 to 2025 net €30,553 ▲31.5% The operating result of €52,175 and the net result of €30,553 are both a record.
Annual accounts 2021 filed PDFmicro format · 11 days before the deadline
Amendment of the articlesGeneral meeting of 24-05-20221 point ▸
- General meeting, 24-05-2022
- The deed holds 11 more points.
2021
Back to profit net €23,236 The net result is €23,236, after 2 loss-making years.
Annual accounts 2020 filed PDFmicro format · 16 days before the deadline
2020
Annual accounts 2019 filed PDFmicro format · 36 days before the deadline
2019
First establishment Rijksweg 71, Maarkedal
IncorporationFounding capital of €431,029.39, 25,742 shares · Demerger: JOVI splits off to ALPHADERM · Appointments: STAELENS Viviane Yvonne Berthe, DE PAUW Jozef Eduard Rachel and DE PAUW Eva Esther Ann · published on 22-08-201911 points ▸
- Founding capital, €431,029.39, 25,742 shares
- STAELENS Viviane Yvonne Berthe holds 12,904 shares
- DE PAUW Jozef Eduard Rachel holds 12,828 shares
- DE PAUW Sarah Suzanrie Wivina holds 5 shares
- DE PAUW Eva Esther Ann holds 5 shares
- Registered office clause, Jezuïetenplein 14, 9700 Oudenaarde
- Director appointment, STAELENS Viviane Yvonne Berthe (director (not named in the articles))
- Director appointment, DE PAUW Jozef Eduard Rachel (director (not named in the articles))
- Director appointment, DE PAUW Eva Esther Ann (director (not named in the articles))
- Director appointment, STAELENS Viviane Yvonne Berthe (managing director)
- Director appointment, DE PAUW Jozef Eduard Rachel (managing director)
- The deed holds 6 more points.
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
ALPHADERM was incorporated on 29 July 2019 as a private limited company by four natural persons, with a starting capital of €431,029.12 The registered office was moved to Nukerke in 2024.3 The board currently has 3 members.4 Total assets rose from €890,487 in 2019 to €1.2m in 2025 and headcount from 1.6 full-time equivalents in 2020 to 2.2 in 2025.5